AI-assisted, human-published
03/24/2025 /Funding Events
Tempero Bio Secures $70M for Substance Use Disorder Treatments
Clinical-stage biopharmaceutical company, Tempero Bio, successfully concludes a Series B financing round raising $70 million to advance TMP-301, a potential treatment for substance use disorders.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com